Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NanoBioMagnetics Announces Issuance of US Patent

Abstract:
Officials of NanoBioMagnetics, Inc., (NBMI) today announced the issuance of its first patent by the U.S. Patent and Trademark Office. The patent, titled "Method and Apparatus for Improving Hearing," is based on the use of magnetically responsive nanoparticles implanted in the organs of the middle ear to drive tissue vibrations in the amplification of sound.

NanoBioMagnetics Announces Issuance of US Patent

Edmond, OK | Posted on March 24th, 2008

The technology was the first demonstration of the nanomechanical movement of tissue and operates in
principle much like a typical commercial electromagnetic hearing aid. Development and validation was
done during 2002 - 2004. The company now will move the technology through commercialization
partnerships.

Statistics of the National Institutes of Health indicate sensorineural hearing loss affects approximately 28 million Americans. The technology covered by today's patent has the potential to move hearing aid systems to smaller and totally implantable hearing devices, achieving more favorable patient economics, performance and compliance.

Charles Seeney, CEO and Founder of NBMI, and co-inventor on the patent, said "miniaturization of
hearing devices through ever smaller electronic components is part of an emerging trend based on
applying nanotechnology to human healthcare needs." A companion technology, based on the targeted
delivery of bioactive materials to the inner ear, continues under development. The company also has in progress major research collaborations assessing the tumor-specific delivery of cancer therapeutics, research for which is ongoing at the M D Anderson Cancer Center in Houston.

NBMI is a nanobiomaterials company, with core technology focused on designed structures of
magnetically responsive nanoparticles to cause or drive a desired physiological event. Its healthcare technologies are developed and validated through collaborations with academic and industrial institutions. NBMI's hearing amplification technology was developed in part through collaborations with the University of Oklahoma and the Massachusetts Eye and Ear Infirmary, an affiliate of Harvard Medical School.

Today's issuance is viewed as Oklahoma's first nanotechnology-based patent for a healthcare
application.


####

About NanoBioMagnetics, Inc.
NanoBioMagnetics (NBMI) is a nanobiomaterials company pioneering an emerging area of nanomedicine referred to as organ-assisting-device (OAD) technologies. The company has developed a targeted therapeutic delivery methodology in which designed configurations of magnetically responsive nanoparticles (MNP), under the influence of external shaped magnetic fields, cause or drive a desired physiological event. MNP, single domain and superparamagnetic, respond to an applied magnetic field, returning to their normal state when the field is removed, in effect creating a "biomagnetic" switch. The company is applying this technological concept to a range of human health applications in collaborations with major research institutions across the country, where several scientific "firsts" have been achieved and published.

For more information, please click here

Contacts:
Charles E Seeney
(405) 844-5118

Copyright © NanoBioMagnetics, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

NREL Announces New Center Directors to lead R&D, Analysis Efforts September 30th, 2014

Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Speed at its limits September 30th, 2014

Research mimics brain cells to boost memory power September 30th, 2014

Nanomedicine

Speed at its limits September 30th, 2014

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

Announcements

Park Systems Announces Outsourced Analytical Services Including AFM Surface Imaging, Data Analysis and Interpretation September 30th, 2014

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014

Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014

Patents/IP/Tech Transfer/Licensing

‘Small’ transformation yields big changes September 16th, 2014

Berkeley Lab Licenses Boron Nitride Nanotube Technology: New material has unique mechanical and electronic properties September 13th, 2014

Secure Computing for the ‘Everyman': Quantum computing goes to market in tech transfer agreement with Allied Minds September 2nd, 2014

New analytical technology reveals 'nanomechanical' surface traits August 29th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE